Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Liver Neoplasms 1Fatigue 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Patient Education as Topic × Clear all
NCT07308223 2026-04-06

Development of a Cloud-Based PRO (Patient-Reported Outcome) Management Program for Home-Based Cancer Pain Care

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Phase NA Withdrawn

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡